Page last updated: 2024-09-04

atrasentan and cgs 35066

atrasentan has been researched along with cgs 35066 in 1 studies

Compound Research Comparison

Studies
(atrasentan)
Trials
(atrasentan)
Recent Studies (post-2010)
(atrasentan)
Studies
(cgs 35066)
Trials
(cgs 35066)
Recent Studies (post-2010) (cgs 35066)
358411081801

Protein Interaction Comparison

ProteinTaxonomyatrasentan (IC50)cgs 35066 (IC50)
NeprilysinRattus norvegicus (Norway rat)2.3
NeprilysinOryctolagus cuniculus (rabbit)2.3
NeprilysinHomo sapiens (human)2.3
Angiotensin-converting enzyme Homo sapiens (human)1.161
Endothelin-converting enzyme 1Homo sapiens (human)0.022

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayach, B; Battistini, B; Blouin, A; Cernacek, P; Jeng, AY; Opgenorth, T; Tsang, J; Verreault, M; Wessale, J1

Other Studies

1 other study(ies) available for atrasentan and cgs 35066

ArticleYear
Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
    Journal of cardiovascular pharmacology, 2004, Volume: 44 Suppl 1

    Topics: Acute Disease; Animals; Aspartic Acid Endopeptidases; Atrasentan; Benzofurans; Cardiovascular Agents; Disease Models, Animal; Embolism, Air; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-Converting Enzymes; Endothelins; Hemodynamics; Hypertension, Pulmonary; Male; Metalloendopeptidases; Organophosphonates; Protease Inhibitors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Time Factors; Ventricular Dysfunction, Right

2004